Focused on Life

Creating shareholder value

Press Releases

Title
PDF
Gentium Receives Day 180 List of Outstanding Issues from the CHMP for Defibrotide MAA
May 04, 2012
PDF, 23KB, Opens in a new window
Gentium Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries
May 02, 2012
PDF, 32KB, Opens in a new window
Gentium Hosts Symposium on Defibrotide at EBMT Annual Meeting
Apr 02, 2012
PDF, 21KB, Opens in a new window
Gentium Appoints Dr.Carin Heringa as Senior Vice President and Scientific Director
Mar 06, 2012
PDF, 25KB, Opens in a new window
The Lancet Publishes Results from Gentium’s Phase III Defibrotide Trial for the Prevention of VOD in Paediatric Patients
Feb 27, 2012
PDF, 26KB, Opens in a new window
Gentium Responds to the EMA’s Day 120 List of Questions for Defibrotide MAA
Feb 21, 2012
PDF, 26KB, Opens in a new window
Gentium Appoints Swedish Orphan Biovitrum AB as Exclusive Distributor of Defibrotide in Nordic and Baltic Territories
Jan 09, 2012
PDF, 27KB, Opens in a new window